Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Boschwitz, Theresa Zhang, Felix Dawson

Personal Genome Diagnostics named Jeffrey Boschwitz its chief operating officer, Theresa Zhang its VP of research services, and Felix Dawson to its board. Boschwitz was formerly executive VP of operations and corporate development at Plus Diagnostics. Prior to that, he was VP of North American sales and marketing at Orchid Cellmark and has held positions at Quest Diagnostics and Booz Allen Hamilton. 

Zhang joins PGDx from Merck Research Laboratories where she held various positions responsible for identification of predictive biomarkers and clinical implementation for oncology compounds. Dawson is a founding member of investment firm Wilkes Lane Capital. He previously was at Constellation Energy, now called Exelon, and at Goldman Sachs. 

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.